Jönsson, Linus

Cost of disorders of the brain in Europe 2010

Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology

Mental Health Treatment and AccessHealth Systems, Economic Evaluations, Quality of Life

Cited by 1,723

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 1,676

The worldwide costs of dementia 2015 and comparisons with 2010

Wimo, A., Guerchet, M., Ali, G., Wu, Y., Prina, A. M., Winblad, B., Jönsson, L., Liu, Z., & Prince, M. (2017) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 1,066

The worldwide costs of dementia in 2019

Wimo, A., Seeher, K., Cataldi, R., Cyhlarova, E., Dielemann, J. L., Frisell, O., Guerchet, M., Jönsson, L., Malaha, A. K., Nichols, E., et al. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 559

An estimate of the total worldwide societal costs of dementia in 2005

Wimo, A., Winblad, B., & Jönsson, L. (2007) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 300

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

Xu, H., Garcia-Ptacek, S., Jönsson, L., Wimo, A., Nordström, P., & Eriksdotter, M. (2021) · Neurology

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 182

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

Jönsson, L., Wimo, A., Handels, R., Johansson, G., Boada, M., Engelborghs, S., Frölich, L., Jessen, F., Kehoe, P. G., Kramberger, M., et al. (2023) · The Lancet Regional Health - Europe

Pharmaceutical Economics and PolicyAlzheimer's disease research and treatments

Cited by 129

Dementia prevention: The potential long‐term cost‐effectiveness of the FINGER prevention program

Wimo, A., Handels, R., Antikainen, R., Eriksdotter, M., Jönsson, L., Knapp, M., Kulmala, J., Laatikainen, T., Lehtisalo, J., Peltonen, M., et al. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 66

Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first episode of psychosis: a case-control development and validation study

Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P. (2020) · The Lancet Digital Health

Machine Learning in HealthcareSchizophrenia research and treatment

Cited by 60

Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry

Handels, R., Jönsson, L., Garcia‐Ptacek, S., Eriksdotter, M., & Wimo, A. (2020) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchStatistical Methods and Bayesian Inference

Cited by 34

The Nairobi Declaration—reducing the burden of dementia in low- and middle-income countries (LMICs): declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs

Maestre, G., Carrillo, M., Kalaria, R., Acosta, D., Adams, L., Adoukonou, T., Akinwande, K., Akinyemi, J., Akinyemi, R., Akpa, O., et al. (2023) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchMental Health Treatment and Access

Cited by 31